Wellness

Summary
  • India is one of the pioneers in the alternative system of medicine and has an unparalleled heritage represented by its ancient and age-old traditional treatment methods, such as Ayurveda, Yoga, Unani, Siddha and Homoeopathy *
  • India is a biodiversity rich country and as per the Botanical Survey of India estimation, more than 8,000 species of medicinal plants are found in the country.* 
  • The Ministry of AYUSH was formed in November 2014, to overlook the optimal development and proliferation of the AYUSH systems of health care  *    
  • Market size of AYUSH industry as a whole has grown around 17% during 2014-2020 to reach USD 18.1 bn with the increase in global and domestic demand and enabled by strong support to regulatory, research and development and robust infrastructure by the Ministry of AYUSH.*
  • The market size of the AYUSH industry in India has witnessed a quantum jump from over USD 3 bn in 2014 to USD 18 bn in 2021, clocking a phenomenal annual growth of 75%. *
    
Reasons to Invest
  • The Indian systems of medicine and homoeopathy particularly Ayurveda and Yoga are widely recognised for their holistic approach to health and capability for meeting emerging health challenges. These systems are playing an important role in achieving the national health outcome goals of reducing Maternal Mortality Rate (MMR), Infant Mortality Rate (IMR), malnutrition and anaemia
  • The demand for Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) and herbal products is surging in India and abroad
  • India is the second largest exporter of AYUSH and herbal products. Investors and corporate houses are increasingly investing in AYUSH sector
  • Ayurveda has a unique therapy called Panchkarma which is beneficial for preventive/promotive health care and for treatment of many chronic lifestyle disorders
  • Yoga is widely recognised and practiced in Asian as well as western countries. Several yoga centres/studios have been established across the globe during the last 4-5 decades
  • Yoga is a drugless system and can be applied as an independent modality or as add-on therapy with other systems
  • 8,001 Janaushadhi Kendras opened as on 02.08.2021 covering all the districts of the country. *
  • The GOI has signed 25 MoUs for country to country cooperation in the field of medicine. These are Nepal, Bangladesh, Hungary, Trinidad & Tobago, Malaysia, Mauritius, Mongolia, Turkmenistan, Myanmar, World Health Organization,   Germany, Iran, Sao Tome & Príncipe, Equatorial Guinea, Cuba, Colombia, Japan, Bolivia, Gambia, Republic of Guinea, China, St Vincent and The Grenadines, Suriname, Brazil and Zimbabwe.* 
  • 37 MoUs for undertaking collaborative research and development of Traditional Medicine has been signed with foreign Institutes/Universities/Organizations from USA, Germany, UK, Canada, Malaysia, Brazil, Australia, Austria, Tajikistan, Saudi Arabia, Ecuador, Japan, Indonesia, Reunion Island, Korea and Hungary etc.*
  • 15 MoUs have been signed for setting up of Ayush Academic Chairs in foreign Institutes/Universities from Hungary, Latvia, Mauritius, Bangladesh, Russia, West-Indies, Thailand, Indonesia, Slovenia, Armenia, Argentina, Malaysia, South Africa, Australia and Mexico.*
Key Achievements
  • Hon’ble PM Shri Narendra Modi will inaugurate Institute of Teaching and Research in Ayurveda (ITRA) at Jamnagar and National Institute of Ayurveda (NIA) at Jaipur on 5th Ayurveda Day (i.e) 13th November 2020 via video conferencing. These institutions are expected to play global leadership roles in the growth and development of Ayurveda in the 21st Century. *
  • More than 50,000 (50,025) Ayushman Bharat - Health and Wellness Centres (AB-HWCs) are now operational across the country to providing Comprehensive Primary Health Care (CPHC) services to the communities closer to their homes. *
  • “AYU SAMVAD”(My Health My Responsibility) is one of the largest public awareness campaign programs on AYURVEDA and COVID 19 PANDEMIC, organized by All India Institute of Ayurveda New Delhi.
  • MoU signed between Regional Ayurveda Research Institute and Sikkim Manipal University for collaborative research. *
  • Ayush-64 is a very effective medicine that helps with the mild and asymptomatic cases of Covid-19. Its supply will increase manifold as fresh license is given to 39 companies i.e. technology has been transferred for use in Covid-19. *
  • Ministry of Ayush's comprehensive document puts forth the concept of ‘Holistic Health’. The recommendations for the public on ‘holistic health and well-being’ focus on preventive measures and care during ‘COVID-19 and Long COVID’-19. *
  • Government has published Ayurvedic Formulary of India (Part I-III) containing 986 Formulations, Siddha Formulary of India (Part I-II) containing 400 Formulations and National Formulary of Unani Medicine (Vol. I-VI) containing 1230 Formulations. *
  • GOI has published monographs of quality standards of 645 Single drugs and 203 Formulations of Ayurveda; 139 Single drugs and 1 Formulation of Siddha; 298 Single drugs and 201 Formulations of Unani; and 1117 drugs of Homoeopathy (Vol. I-X). *
  • 24 Health & Wellness Centres in Mizoram are inaugurated to boost the healthcare infrastructure in the hill state of the Northeast. *
  • The Union Cabinet has approved the establishment of the WHO Global Centre for Traditional Medicine (WHO GCTM) in Jamnagar, Gujarat  under the Ministry of AYUSH by signing a Host Country agreement between the GOI and the World Health Organization (WHO). This would be the first and only global outposted Centre (office) for traditional medicine across the globe. *
  • Patent awarded for use of advanced automated system or instrument for Therapeutic Emesis.*
Recent Announcements

28th November 2022: MoU signed between Ministry of Ayush and Department of Science and Technology for promotion of evidence-based research and scientific intervention in the sector.

Read More

 

24th November 2022: Reforms in Ayush sector to boost growth: Shri Sarbananda Sonowal.

Read More

 

23rd November 2022: Ministry of Ayush announces setting up of Academic Chair in Ayurvedic Science at Western Sydney University, Australia.

Read More

 

21st November 2022: Union Minister Sarbananda Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar.

Read More

 

14th November 2022: India’s Ayush Sector to increase its market share to USD 23 bn globally by 2023: Sarbananda Sonowal.

Read More

Statistics
  • India is a rich country in terms of biodiversity. Of the 17,000-18,000 species of flowering plants found in India, more than 7,000 are estimated to have medicinal usage *
  • Around 1,178 species of medicinal plants are estimated to be in trade, of which 242 species are annually consumed in excess of 100 metric tons/year *
  • Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Ministry of AYUSH has recorded a turnover of Rs 164.33 Crore (tentative figure) for the financial year 2020-21. *
  • An increase of 6.2%, from 0.73 mn Tonne in 2019-20 to 0.78 mn Tonne in 2020-21, has been registered in Aromatic & Medicinal crops. *
  • Buoyed by the growing global and domestic demand and enabled by a strong support to regulatory, research and development and back-end infrastructure, the market size of AYUSH has grown by 17 percent in 2014-20 to reach US dollars 18.1 bn *
  • As per the RIS report, the Ayush industry is projected to reach USD 20.6 bn in 2021 and USD 23.3 bn in 2022. In terms of global share, India accounts for about 2.8 per cent of the market. *
  • There are 7032 Primary Health Centres (PHCs), 2793 Community Health Centres (CHCs) and 484 District Hospitals (DHs) are co-located with AYUSH facilities.*
Growth Drivers
  • MoU signed between PCIM&H and IPC for Inter-Ministerial cooperation for promotion and facilitation of “One Herb, One Standard”.*
  • The diversity of flora in the North East region of India along with the rich heritage of traditional medicine will act as a catalyst for development of AYUSH based industries in the region. *
  • GOI has established Pharmacopoeia Commission for Indian Medicine and Homoeopathy c(PCIM&H) under the Ministry of AYUSH to standardization of Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) medicines in the country. *
  • GOI has signed 25 MoUs for country to country cooperation in the field of medicine. 33 MoUs for undertaking collaborative research and development of Traditional Medicine have been signed with foreign Institutes/Universities/Organizations. 14 MoUs have been signed for setting up of Ayush Academic Chairs in foreign Institutes/Universities *
  • Ministry of AYUSH is also implementing a Central Sector Scheme namely AYURGYAN Scheme for Research & Innovation in AYUSH. Under the scheme, financial support was provided for 311 research projects in Ayush including 34 research projects on COVID-19. *
  • The National Medicinal Plants Board (NMPB) and the Council of Scientific and Industrial Research-Central Institute of Medicinal and Aromatic Plants, (CSIR-CIMAP), Lucknow signed an MoU for extending joint collaborative efforts to promote the production of quality planting material (QPM) of medicinal plants. *
  • Government has formulated action-plan to standardization of Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) medicines in the country and has established Pharmacopoeia Commission for Indian Medicine and Homoeopathy(PCIM&H) under the Ministry of AYUSH to publish and revise Ayurvedic Pharmacopoeia of India (API), Siddha Pharmacopoeia of India (SPI), Unani Pharmacopoeia of India (UPI) and Homoeopathic Pharmacopoeia of India (HPI). *
  • A dedicated storefront for ayurveda products on Amazon.in marketplace will enhance visibility of unique Ayurveda products such as various kinds of juices, skin-care supplements, immunity boosters, oils and more from small businesses and startup brands. *
  • The National Health Authority (NHA) under its flagship scheme of Ayushman Bharat Digital Mission (ABDM) has completed 27 major integrations across Government and private sector. These integrations with organizations offers Health Management Information Systems (HMIS), Laboratory Management Information Systems (LMIS), health locker services, health tech services and other digital services are a step towards developing a user-inclusive, integrated and interoperable digital healthcare eco-system for the country. *
  • 32 MoUs have been signed with international institutes for undertaking Collaborative Research / Academic collaboration. *
  • The Ministry of Ayush and Ministry of Defence decided to operationalise Ayurveda Centres at 37 Cantonment Hospitals & 12 AFMS military hospitals across the country to integrate Ayurveda into the health establishment. *
  • E-commerce platforms have been advised that the sale or facilitating the sale of such drugs shall be done only after a valid prescription of a registered Ayurveda, Siddha or Unani practitioner respectively is uploaded by the user on the platform. *
  • The constituent laboratory of Council of Scientific & Industrial Research namely Institute of Himalayan Bio-resource Technology (CSIR-IHBT), Palampur has signed an MoU with National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan, to collaborate in the areas of mutual interest which included medicinal plants, bioactive molecules, herbal formulations etc.*
  • CSIR and Bill & Melinda Gates Foundation have signed an MoU to identify the opportunities for scientific and technological research between researchers located within and outside of India, including collaborations with foundation-funded entities in the areas including but not limited to traditional medicine (AYUSH)-guided by specific applications to disease/ health priorities.*
  • Ministry of Ayush signed an MoU with Ministry of Railway for Introduction of Ayush Systems in five Railways Hospitals resulting into establishment of Ayush units at 5 Railway zonal hospitals at Delhi, Mumbai, Chennai, Kolkata and Guwahati.*
FDI Policy
  • 100% FDI is permitted in the AYUSH sector.*
Sector Policy

Ayush Mark Certification Scheme*

  • It is a voluntary certification scheme for ASU&H products having two levels: Ayush Standard Mark and Ayush Premium Mark.

  • The Ayush Standard Mark is based on Good Manufacturing Practices (GMP) for Ayurvedic, Siddha and Unani medicines (ScheduleT) as per Drugs and Cosmetic Rules, 1945. AYUSH Premium Mark is based on WHO’s GMP guidelines covering herbal medicines.

  • For any manufacturer to qualify for AYUSH Mark Certification, compliance to the domestic regulations is a pre-requisite. The products are certified post regulatory approval given by State Licensing Authority of the state government concerned.

Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana (AOGUSY)*

  • Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana (AOGUSY) of Ministry of Ayush has been initiated for augmenting quality of Ayush drugs during the 15th Finance Cycle (2021-22 to 2025-26) by merging the existing Central Sector Schemes of Pharmacovigilance initiative, Central Drug Controller of Ayush and Quality Control of ASU&H drugs {Component of National Ayush Mission (NAM)} and inclusion of certain new elements. 

  • The Yojana aims to facilitate standardization, effective enforcement of rules/regulations, technology up-gradation for manufacturing and analytical testing, certification/accreditation, training and capacity building activities intended towards quality assurance of Ayush drugs.

Ayushman Bharat (Pradhan Mantri Jan Arogya Yojana (PM-JAY))

  • Ayushman Bharat, a flagship scheme of Goverment of India was launched as recommended by the National Health Policy 2017, to achieve the vision of Universal Health Coverage (UHC). This initiative has been designed on the lines as to meet SDG and its underlining commitment, which is "leave no one behind".
  • Ayushman Bharat is an attempt to move from sectoral and segmented approach of health service delivery to a comprehensive need-based health care service. Ayushman Bharat aims to undertake path breaking interventions to holistically address health (covering prevention, promotion and ambulatory care), at primary, secondary and tertiary level. For more details, Refer to Ayushman Bharat.

National Ayush Mission *

The National Ayush Mission (NAM) aims to promote Ayurveda, Siddha and Unani and Homoeopathy drugs in the country. It also aims to make provisions for the sustainable availability of Ayush, Siddha, Unani and Homoeopathy raw materials.17 This mission was launched on 15th September 2014 which is a Centrally Sponsored Scheme having financial implication of INR 4,607.30 cr (INR 3,000 cr as Central Share and INR 1,607.30 cr as State Share) from 01-04-2021 to 31-03-2026.

The objectives of NAM are as follows 

  1. Provide cost-effective AYUSH services with universal access by upgrading AYUSH hospitals and dispensaries, co-location of AYUSH facilities at primary health centres (PHCs), community health centres (CHCs) and district hospitals (DHs).
  2. To strengthen institutional capacity at the state level by upgrading AYUSH educational institutions, State government Ayurveda, Siddha and Unani and Homoeopathy pharmacies, drug testing laboratories and Ayurveda, Siddha and Unani and Homoeopathy enforcement mechanism.
  3. Support cultivation of medical plants by adopting Good Agricultural Practices (GAP) to provide sustained supply of quality raw materials and support certification mechanism for quality standards, good agricultural/collection/storage practices.  
  • Ministry of AYUSH has rolled out a set of initiatives to improve Financial Management and accelerate Governance Reforms.  These initiatives have two thrust areas, namely the Government Schemes (both Central Sector and Centrally Sponsored) and the Autonomous Bodies of the Ministry.
  • Providing cost-effective AYUSH Services, with universal access through upgrading AYUSH Hospitals and Dispensaries, co-location of AYUSH facilities at Primary Health Centers (PHCs), Community Health Centers (CHCs) and District Hospitals (DHs), strengthening institutional capacity at the State level through upgrading AYUSH educational institutions.
  • Setting up of new upto 50 bedded integrated AYUSH Hospital, AYUSH Public Health programmes and operationalization of 12,500 AYUSH Health and Wellness Centres to provide services of a holistic wellness model based on AYUSH principles and practices so as to empower masses for "self-care" to reduce the disease burden, and out of the pocket expenditure.
  • To encourage the farmers for cultivation of Medicinal Plants, the Ministry has provided subsidy @30%, 50% and 75% of cultivation cost of prioritized plant species throughout the country
  • Under the National AYUSH Mission (NAM), there is a provision for Infrastructural development of AYUSH Under-Graduate Institutions and Post-Graduate Institutions.
  • A total amount of INR 553.36 crore has been released by the GOI to Uttar Pradesh for various activities under the National AYUSH Mission.
  • , the total budget of INR 3119.46 crores has been allocated/ released as a central share to States/UTs since the inception of the scheme and they have reported an expenditure of INR 2290.20 crores.

Champion Service Sector Scheme: *

  • Ministry of AYUSH established AYUSH Health Care Super Specialty Day Care / Hospital under Champion Service Sector Scheme with the provision of INR 769 cr. for three years in collaboration with the Ministry of Commerce.

 

For more information, please refer to National Ayush Mission.

Financial Support

Key Highlights of Budget 2022-23:

  • Ayush Ministry’s budget allocation stands up at INR 3,050 Cr, 4-fold increase over 7 years.
Investment Opportunities
  • Ayurveda drug manufacturing (nutraceuticals, food supplements, cosmetics and rejuvenates).
  • Setting up of specialised treatment centres.
  • Medical tourism for curative and rejuvenation treatments.
  • Objectives of National AYUSH Mission: 

    • Provide cost effective AYUSH services with universal access by upgrading AYUSH hospitals and dispensaries, co-location of AYUSH facilities at primary health centres (PHCs), community health centres (CHCs) and district hospitals (DHs).

    • Strengthen institutional capacity at the state level by upgrading AYUSH educational institutions, State government Ayurveda, Siddha and Unani and Homoeopathy pharmacies, drug testing laboratories and Ayurveda, Siddha and Unani and Homoeopathy enforcement mechanism.
    • Support cultivation of medical plants by adopting Good Agricultural Practices (GAP) to provide sustained supply of quality raw materials and support certification mechanism for quality standards, good agricultural/collection/storage practices.
Agencies
Sources
  1. “Medical Value Travel in India", FICCI, http://www.ficci.in/Medical-Value-Travel-Report.pdf
  2. "India Pharma and Healthcare Sector 2019/2023", EMIS, https://www.emis.com/php/store/reports/IN/India_Pharma_and_Healthcare_Sector_Report_20192023_en_646360982.html
  3. Ministry of Ayush, https://health.ncog.gov.in/
  4. Ministry of Ayush, https://health.ncog.gov.in/
  5. "Introduction", National Medicinal Plants Board, https://nmpb.nic.in/content/introduction
  6. "Introduction", National Medicinal Plants Board, https://nmpb.nic.in/content/introduction
  7. "Introduction", National Medicinal Plants Board, https://nmpb.nic.in/content/introduction
  8. "Over 50 Lakh Benefit under Ayushman Bharat", PIB,  https://pib.gov.in/PressReleseDetail.aspx?PRID=1588099
  9. Wellness and Beauty: An ecosystem in the making”, FICCI, http://ficci.in/publication.asp?spid=23105
  10. “Nearly 16% growth in Foreign Tourist Arrivals for Medical Tourism in 2017: Shri K. J. Alphons", PIB, https://pib.gov.in/PressReleasePage.aspx?PRID=1556223
  11. “Nearly 16% growth in Foreign Tourist Arrivals for Medical Tourism in 2017: Shri K. J. Alphons", PIB, https://pib.gov.in/PressReleasePage.aspx?PRID=1556223
  12. “Nearly 16% growth in Foreign Tourist Arrivals for Medical Tourism in 2017: Shri K. J. Alphons", PIB, https://pib.gov.in/PressReleasePage.aspx?PRID=1556223
  13. “Cabinet Approves Memorandum of Understanding between India and Sao Tome and Principe for Cooperation in the field of Traditional Systems of Medicine and Homoeopathy", PIB, https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1530142
  14. “Cabinet Approves Memorandum of Understanding between India and Sao Tome and Principe for Cooperation in the field of Traditional Systems of Medicine and Homoeopathy", PIB, https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1530142
  15. “Cabinet Approves Memorandum of Understanding between India and Sao Tome and Principe for Cooperation in the field of Traditional Systems of Medicine and Homoeopathy", PIB, https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1530142
  16. Consolidated FDI Policy, https://invest-india-revamp-static-files.s3.ap-south-1.amazonaws.com/2020-04/FDI%20Policy%202019%20revised_19%20April%202020.pdf
  17. "National Health Policy 2017", National Health Portal,   https://www.nhp.gov.in/nhpfiles/national_health_policy_2017.pdf
  18. “National Ayush Mission", Ministry of AYUSH, https://nmpb.nic.in/sites/default/files/downloads/4197396897-Charakasamhita_ACDP_english_0.pdf
  19. “Summary of Union Budget 2020-21”, PIB, https://pib.gov.in/PressReleseDetail.aspx?PRID=1601475
  20. PIB, https://pib.gov.in/PressReleasePage.aspx?PRID=1646461
  21. PIB, https://www.pib.gov.in/PressReleasePage.aspx?PRID=1671893
  22. PIB Release, https://www.pib.gov.in/PressReleasePage.aspx?PRID=1674004
  23. PIB Release, https://www.pib.gov.in/PressReleasePage.aspx?PRID=1674243
  24. PIB Release, https://www.pib.gov.in/PressReleasePage.aspx?PRID=1683320
  25. PIB Release,  https://www.pib.gov.in/PressReleasePage.aspx?PRID=1711702

Have a Query? Connect to us